Lam Research Corporation $LRCX Shares Sold by Rothschild Investment LLC

Rothschild Investment LLC lessened its holdings in shares of Lam Research Corporation (NASDAQ:LRCX) by 13.9% during the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 3,684 shares of the semiconductor company’s stock after selling 595 shares during the period. Rothschild Investment LLC’s holdings in Lam Research were worth $359,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in the business. Empowered Funds LLC increased its position in shares of Lam Research by 10.5% during the first quarter. Empowered Funds LLC now owns 187,472 shares of the semiconductor company’s stock worth $13,629,000 after purchasing an additional 17,833 shares in the last quarter. Genus Capital Management Inc. acquired a new stake in shares of Lam Research in the 2nd quarter valued at about $14,476,000. Cookson Peirce & Co. Inc. purchased a new position in Lam Research during the 1st quarter worth approximately $607,000. Sava Infond d.o.o. grew its stake in Lam Research by 3.1% during the 2nd quarter. Sava Infond d.o.o. now owns 75,250 shares of the semiconductor company’s stock worth $7,325,000 after buying an additional 2,250 shares during the last quarter. Finally, Glass Wealth Management Co LLC increased its position in Lam Research by 8.5% during the second quarter. Glass Wealth Management Co LLC now owns 28,870 shares of the semiconductor company’s stock worth $2,810,000 after buying an additional 2,270 shares during the period. Hedge funds and other institutional investors own 84.61% of the company’s stock.

Insider Activity at Lam Research

In other Lam Research news, CFO Douglas R. Bettinger sold 40,080 shares of the stock in a transaction dated Friday, November 14th. The shares were sold at an average price of $150.60, for a total value of $6,036,048.00. Following the completion of the transaction, the chief financial officer directly owned 987,237 shares of the company’s stock, valued at approximately $148,677,892.20. This trade represents a 3.90% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Ava Harter sold 9,010 shares of Lam Research stock in a transaction that occurred on Monday, October 27th. The shares were sold at an average price of $157.47, for a total transaction of $1,418,804.70. Following the sale, the insider owned 56,786 shares of the company’s stock, valued at approximately $8,942,091.42. The trade was a 13.69% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 102,608 shares of company stock worth $14,916,496. 0.31% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on LRCX. Erste Group Bank started coverage on Lam Research in a report on Thursday, August 14th. They issued a “buy” rating for the company. Morgan Stanley increased their price objective on Lam Research from $125.00 to $137.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 23rd. Susquehanna lifted their target price on Lam Research from $135.00 to $200.00 and gave the company a “positive” rating in a research note on Thursday, October 23rd. Cowen restated a “buy” rating on shares of Lam Research in a research note on Thursday, October 23rd. Finally, Barclays set a $142.00 price target on Lam Research and gave the stock an “equal weight” rating in a report on Monday, October 20th. One research analyst has rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat.com, Lam Research presently has an average rating of “Moderate Buy” and an average target price of $149.04.

Lam Research Stock Performance

Shares of LRCX stock opened at $143.24 on Wednesday. The company has a current ratio of 2.21, a quick ratio of 1.60 and a debt-to-equity ratio of 0.37. The stock has a 50 day simple moving average of $142.35 and a 200-day simple moving average of $110.96. The company has a market cap of $179.91 billion, a price-to-earnings ratio of 31.55, a price-to-earnings-growth ratio of 1.68 and a beta of 1.87. Lam Research Corporation has a 12-month low of $56.32 and a 12-month high of $167.15.

Lam Research (NASDAQ:LRCX) last announced its quarterly earnings data on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share for the quarter, topping analysts’ consensus estimates of $1.22 by $0.04. The firm had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.23 billion. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.Lam Research’s quarterly revenue was up 27.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.86 earnings per share. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. On average, equities analysts forecast that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 7th. Stockholders of record on Wednesday, December 3rd will be paid a dividend of $0.26 per share. The ex-dividend date of this dividend is Wednesday, December 3rd. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.7%. Lam Research’s dividend payout ratio is 22.91%.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.